Annovis Bio, Inc.
ANVS- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001477845
No open-market purchases or sales by Annovis Bio, Inc. insiders were filed in the last 90 days; 61 institutions reported holding it in 13F filings for Q2 2026, worth $20.2M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Annovis Bio, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- +5 vs. Q3 2024
- Shares held
- 1.58M
- +396.7K (+33.6%) vs. Q3 2024
- Total value
- $7.93M
- −$1.58M (−16.6%) vs. Q3 2024
- New holders
- 9
- 13 more added
- Sold out
- 4
- 8 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ANVS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 61 | $20.2M |
| Q1 2026 | 56 | $10.5M |
| Q4 2025 | 53 | $14.7M |
| Q3 2025 | 42 | $4.19M |
| Q2 2025 | 42 | $3.93M |
| Q1 2025 | 44 | $3.13M |
| Q4 2024 | 40 | $7.93M |
| Q3 2024 | 35 | $9.50M |
| Q2 2024 | 31 | $5.67M |
| Q1 2024 | 31 | $14.3M |
| Q4 2023 | 36 | $22.5M |
| Q3 2023 | 30 | $10.6M |
| Q2 2023 | 28 | $18.3M |
| Q1 2023 | 23 | $11.6M |
| Q4 2022 | 23 | $9.93M |
| Q3 2022 | 25 | $10.0M |
| Q2 2022 | 26 | $8.73M |
| Q1 2022 | 24 | $11.9M |
| Q4 2021 | 32 | $19.6M |
| Q3 2021 | 38 | $36.2M |
| Q2 2021 | 57 | $109.0M |
| Q1 2021 | 31 | $23.1M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Annovis Bio, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 466,277 | $2.35M | 0.00% | +86,022+22.6% | Added |
| Citadel Advisors LLC | 215,207 | $1.08M | 0.00% | +112,515+109.6% | Added |
| BlackRock, Inc. | 111,979 | $563.3K | 0.00% | +10,484+10.3% | Added |
| Geode Capital Management, LLC | 99,564 | $501.0K | 0.00% | +450+0.5% | Added |
| Merit Financial Group, LLC | 98,516 | $495.5K | 0.01% | +71,816+269.0% | Added |
| Jane Street Group, LLC | 68,107 | $342.6K | 0.00% | +47,901+237.1% | Added |
| Susquehanna International Group, LLP | 55,312 | $278.2K | 0.00% | +23,792+75.5% | Added |
| Cubist Systematic Strategies, LLC | 51,347 | $258.3K | 0.00% | +51,347 | New |
| UBS Group AG | 48,736 | $245.1K | 0.00% | +46,889+2,538.7% | Added |
| Wescott Financial Advisory Group, LLC | 41,607 | $209.3K | 0.02% | 00.0% | Unchanged |
| State Street Corp | 38,435 | $193.3K | 0.00% | +2,400+6.7% | Added |
| Northern Trust Corp | 32,780 | $164.9K | 0.00% | +10,846+49.4% | Added |
| Greenwich Wealth Management LLC | 31,951 | $161.0K | 0.01% | +15,476+93.9% | Added |
| Group One Trading, L.P. | 26,206 | $131.8K | 0.00% | −26,561−50.3% | Reduced |
| Sterling Investment Advisors, Ltd. | 23,974 | $120.6K | 0.03% | −10,500−30.5% | Reduced |
| Bridgeway Capital Management, LLC | 21,400 | $107.6K | 0.00% | −700−3.2% | Reduced |
| Spears Abacus Advisors LLC | 20,000 | $100.6K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 19,058 | $95.9K | 0.00% | −10.0% | Reduced |
| Lokken Investment Group LLC | 18,235 | $91.7K | 0.04% | +6,000+49.0% | Added |
| Atria Wealth Solutions, Inc. | 13,002 | $65.4K | 0.00% | +13,002 | New |
| XTX Topco Ltd | 11,653 | $58.6K | 0.00% | +11,653 | New |
| Two Sigma Investments, LP | 10,923 | $54.9K | 0.00% | +10,923 | New |
| Creative Planning | 10,460 | $52.6K | 0.00% | +10,460 | New |
| Wealthspire Advisors, LLC | 10,050 | $50.6K | 0.00% | +50+0.5% | Added |
| Wells Fargo & Company | 9,746 | $49.0K | 0.00% | 00.0% | Unchanged |
| Bryn Mawr Trust Co | 9,393 | $47.2K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 3,800 | $19.1K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,768 | $8.89K | 0.00% | −1,319−42.7% | Reduced |
| R Squared Ltd | 1,520 | $7.65K | 0.01% | +1,520 | New |
| Morgan Stanley | 1,300 | $6.54K | 0.00% | −50−3.7% | Reduced |
| DiNuzzo Private Wealth, Inc. | 1,000 | $5.03K | 0.00% | +1,000 | New |
| Bokf, NA | 555 | $2.71K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 502 | $2.52K | 0.00% | −698−58.2% | Reduced |
| SBI Securities Co., Ltd. | 403 | $2.03K | 0.00% | +403 | New |
| Rhumbline Advisers | 350 | $1.76K | 0.00% | 00.0% | Unchanged |
| Game Plan Financial Advisors, LLC | 200 | $1.00K | 0.00% | 00.0% | Unchanged |
| WR Wealth Planners, LLC | 150 | $755 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 84 | $423 | 0.00% | −5,996−98.6% | Reduced |
| EverSource Wealth Advisors, LLC | 83 | $417 | 0.00% | 00.0% | Unchanged |
| Caitong International Asset Management Co., Ltd | 79 | $397 | 0.00% | +79 | New |
| Quest Partners LLC | 0 | $0 | 0.00% | −46,002−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −24,410−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −13,500−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −8,605−100.0% | Sold out |